BU-NOT-SET

CONTACT US
Regulatory requirements for drug substances
  • Drug substance
Product check
Insight
The QbD approach: Key advantages in clinical and commercial phases
  • Analytical chemistry
Lab
Insight
Sustainability report 2020
  • Sustainability
Report
Report
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Fact sheet
  • Drug product
Stability studies and analysis for consumer health products
Insight
  • Analytical chemistry
Stability studies are ever changing: Outsourcing as a viable option
Insight
  • Drug substance
Navigating the regulatory landscape for controlled substances
eBook
  • Manufacturing
How to speed up vaccine development and production
Insight
  • Analytical chemistry
Reducing time to market with analytical chemistry
Insight
  • Manufacturing
Serialisation – Looking for value-added opportunities
Insight
  • Analytical chemistry
Outlining the key steps to analytical method development
Insight
  • Drug product
Outsourcing formulation development & manufacturing
Insight
  • Drug product
Complying with Annex 1: Things to bear in mind